Ping Rawson
Chief Financial Officer
Replay available
Dyadic International, Inc. (DYAI) Q1 2026 Earnings Call
Dyadic International, Inc. (NASDAQ: DYAI) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joe Hazelton
President and Chief Operating Officer
Mark Edenfarb
Chief Executive Officer
Matt Hewitt
Analyst, Craig Hallam Capital Group
Luis Garcia
Private Investor
Glenn Primack
Analyst, Lusa Investment Group
Tony Bowers
Analyst, Introact
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Dyadic International, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.298 Good evening, and welcome to Dyadic International's Q1 2026 00:00:05.298 -- 00:00:10.385 conference call. Currently, all participants are in a listen-only mode. 00:00:10.385 -- 00:00:15.431 Following management's prepared remarks, there will be a brief question and answer session. 00:00:15.431 -- 00:00:20.398 As a reminder, this conference call is being recorded today, May 13th, 2026. 00:00:20.398 -- 00:00:21.800 I 00:00:21.800 -- 00:00:23.802 would now like to turn the call over to Ms. 00:00:23.802 -- 00:00:26.766 Ping Rawson, Dyadic's Chief Financial Officer. 00:00:26.766 -- 00:00:28.769 Please go ahead. 00:00:28.769 -- 00:00:34.737 Thank you, operator. Good evening and welcome everyone to DIADC's first quarter 2026 00:00:34.737 -- 00:00:40.264 conference call. I hope you have had the opportunity to review DIADC's press releases 00:00:40.264 -- 00:00:45.528 announcing financial results for the quarter ended March 31st, 2026. 00:00:45.871 -- 00:00:50.977 You may access our release and form 10-Q and the investor section of the company's 00:00:50.977 -- 00:00:54.019 website at diadc.com. 00:00:54.470 -- 00:00:59.555 On today's call, our President and Chief Operating Officer, Joe Hazelton, will 00:00:59.555 -- 00:01:02.117 review our Q1, 2026 00:01:02.117 -- 00:01:07.122 Business and Corporate Highlights and provide commentary on the strategic 00:01:07.122 -- 00:01:09.665 direction of the business. 00:01:09.665 -- 00:01:14.769 Our CEO, Mark Edenfarb, will provide an update on our biopharmaceutical 00:01:14.769 -- 00:01:16.171 programs. 00:01:16.171 -- 00:01:21.516 And I will follow with a review of our financial results in more detail, after which 00:01:21.516 -- 00:01:25.334 we will hold a brief Q&A session 00:01:25.334 -- 00:01:29....